Article
Recommendations for pharmacogenetic testing in clinical practice guidelines in the US
23 Apr 2024
Abstract excerpt
PURPOSE: Pharmacogenetic testing can identify patients who may benefit from personalized drug treatment. However, clinical uptake of pharmacogenetic testing has been limited. Clinical practice guidelines recommend biomarker tests that the guideline authors deem to have demonstrated clinical utility, meaning that testing improves treatment outcomes. The objective of this narrative review is to describe the current...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
